Abstract
Background: The world’s population is aging, and more people are living with chronic conditions including diabetes mellitus. Healthcare providers are moving towards the use of telemonitoring to identify patient self-management approaches and ensure the delivery of health care at their home.Aim: to explore three telemonitoring technologies that intend to achieve self-management of Type 2 diabetes mellitus thereby improve HbA1c levels and quality of life.Methods: Interrupted time series design to evaluate the impact of three different telemonitoring solutions provided by one large combined health and social care Trust with technology-naive people, aiming to manage their Type 2 diabetes mellitus.Sample: A total of 166 patients met the criteria at the diabetes clinic, with 29 patients consenting to take part in the study.Results: participants’ baseline measurements were similar. The d-Nav solution exhibited significant improvement in HbA1c over the other telemonitoring solutions. Participants showed acceptability and significant satisfaction of using all three solutions and exhibited improved quality of life.Conclusion: This exploratory study demonstrates the feasibility of using telemonitoring to self-manage Type 2 diabetes mellitus offering a line of communication between the patient and their clinical care team at a distance.
Highlights
The prevalence of type-2 diabetes mellitus (T2DM) is increasing rapidly worldwide [1]
In 2000, the prevalence of T2DM was estimated to be 2.8 percent of the world’s population, which meant that 171 million people were living with diabetes mellitus around the world and it was projected that the number would increase to 366 million by 2030 (WHO 2016) [2]
Three of the remaining four participants consented but did not use the technology to manage their T2DM and one participant withdrew from the study before starting
Summary
The prevalence of type-2 diabetes mellitus (T2DM) is increasing rapidly worldwide [1]. In 2000, the prevalence of T2DM was estimated to be 2.8 percent of the world’s population, which meant that 171 million people were living with diabetes mellitus around the world and it was projected that the number would increase to 366 million by 2030 (WHO 2016) [2]. In 2014, the World Health Organization estimated the prevalence of T2DM amongst adults to be 9 percent of the world’s population that is equivalent to 450 million people living with diabetes in addition to 179 million people living with undiagnosed diabetes [3]. The world’s population is aging, and more people are living with chronic conditions including diabetes mellitus [4,5]. The world’s population is aging, and more people are living with chronic conditions including diabetes mellitus. Healthcare providers are moving towards the use of telemonitoring to identify patient self-management approaches and ensure the delivery of health care at their home
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Current Trends in Biomedical Engineering & Biosciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
